Surgical Treatment of Serous Cystadenomas Neoplasm of the Pancreas

  • Feng Cao
  • Fei LiEmail author


Serous cystadenomas neoplasms (SCNs) of the pancreas is a relatively uncommon cystic lesion, firstly reported by Compagno in 1978 [1]. Approximately 60% of the SCNs affect women with the mean age at presentation of 60 years old. SCN may generate in any portion of the pancreas but most frequently occurs in body and tail. In rare cases, SCNs can involve almost the full length of the pancreas. The diameter of the tumor ranges from less than 1 cm to more than 20 cm, with the mean size of 4–5 cm on resection [2, 3].


  1. 1.
    Compagno J, Oertel JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol. 1978;69:289–98.CrossRefGoogle Scholar
  2. 2.
    Antonini F, Fuccio L, Fabbri C, et al. Management of serous cystic neoplasms of the pancreas. Expert Rev Gastroenterol Hepatol. 2015;9:115–25.CrossRefGoogle Scholar
  3. 3.
    Charville GW, Kao CS. Serous neoplasms of the pancreas: a comprehensive review. Arch Pathol Lab Med. 2018;142:1134–40.CrossRefGoogle Scholar
  4. 4.
    Jais B, Rebours V, Kim MH, et al. Pancreatic serous cystadenoma related mortality is nil. Results of a multinational study under the auspices of the International Association of Pancreatology and the European Pancreatic Club. Gastroenterology. 2014;146(Suppl 1):S137.CrossRefGoogle Scholar
  5. 5.
    Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumors of the Digestive system. 4th ed: WHO Press; 2010.Google Scholar
  6. 6.
    Lillemoe KD, Jarnagin WR. Hepatobiliary and pancreatic surgery: Lippincott Williams & Wilkins, Wolters Kluwer; 2013.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Xuanwu Hospital, Capital Medical UniversityBeijingChina

Personalised recommendations